「臨床試験の段階」の写真・グラフィックス・映像
- 提供元
- 日付
- 種類
- 向き
- カテゴリ
- 色
- 同義語オン
- 提供元
- 日付
- 24時間以内 0
- 48時間以内 0
- 72時間以内 0
- 7日以内 0
- 30日以内 0
- 1年以内 0
- 期間を指定 9
- 日付指定なし 9
- 種類
- 写真 9
- グラフィックス 0
- 映像 0
- 向き
- 縦 0
- 横 9
- 正方形 0
- カテゴリ
- ニュース
- スポーツ
- エンターテインメント
- 教育向け
- カテゴリ指定なし
- 色
- カラー 9
- モノクロ 0
- 同義語辞書
- 古い順
- 1
- 古い順
2020年09月09日Beijing: A china-made coVID-19 vaccine trade fair has made its debutSeptember 8, 2020, Beijing, Beijing, China: BeijingCHINA-On September 6, 2020, at the China International Trade in Services Fair 2020 in Beijing, domestic coVID-19 vaccines made their debut, attracting attention. Among them, the national medicine group China biological exhibited two new crown inactivated vaccine, now all are in the final period of ﾃ｢窶ｦﾂ｢ clinical trials. Will be on display at the firm sinovac coronavirus inactivated vaccines (Vero cell), at present also has entered the stage of ﾃ｢窶ｦﾂ｢ phase of clinical trial. (Credit Image: © SIPA Asia via ZUMA Wire)、クレジット：©ＳＩＰＡ Ａｓｉａ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｃｈｉｎａ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2020091007583
2020年09月09日Beijing: A china-made coVID-19 vaccine trade fair has made its debutSeptember 8, 2020, Beijing, Beijing, China: BeijingCHINA-On September 6, 2020, at the China International Trade in Services Fair 2020 in Beijing, domestic coVID-19 vaccines made their debut, attracting attention. Among them, the national medicine group China biological exhibited two new crown inactivated vaccine, now all are in the final period of ﾃ｢窶ｦﾂ｢ clinical trials. Will be on display at the firm sinovac coronavirus inactivated vaccines (Vero cell), at present also has entered the stage of ﾃ｢窶ｦﾂ｢ phase of clinical trial. (Credit Image: © SIPA Asia via ZUMA Wire)、クレジット：©ＳＩＰＡ Ａｓｉａ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｃｈｉｎａ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2020091007466
2020年09月09日Beijing: A china-made coVID-19 vaccine trade fair has made its debutSeptember 8, 2020, Beijing, Beijing, China: BeijingCHINA-On September 6, 2020, at the China International Trade in Services Fair 2020 in Beijing, domestic coVID-19 vaccines made their debut, attracting attention. Among them, the national medicine group China biological exhibited two new crown inactivated vaccine, now all are in the final period of ﾃ｢窶ｦﾂ｢ clinical trials. Will be on display at the firm sinovac coronavirus inactivated vaccines (Vero cell), at present also has entered the stage of ﾃ｢窶ｦﾂ｢ phase of clinical trial. (Credit Image: © SIPA Asia via ZUMA Wire)、クレジット：©ＳＩＰＡ Ａｓｉａ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｃｈｉｎａ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2020091007680
2020年09月09日Beijing: A china-made coVID-19 vaccine trade fair has made its debutSeptember 8, 2020, Beijing, Beijing, China: BeijingCHINA-On September 6, 2020, at the China International Trade in Services Fair 2020 in Beijing, domestic coVID-19 vaccines made their debut, attracting attention. Among them, the national medicine group China biological exhibited two new crown inactivated vaccine, now all are in the final period of ﾃ｢窶ｦﾂ｢ clinical trials. Will be on display at the firm sinovac coronavirus inactivated vaccines (Vero cell), at present also has entered the stage of ﾃ｢窶ｦﾂ｢ phase of clinical trial. (Credit Image: © SIPA Asia via ZUMA Wire)、クレジット：©ＳＩＰＡ Ａｓｉａ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｃｈｉｎａ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2020091007717
2020年09月09日Beijing: A china-made coVID-19 vaccine trade fair has made its debutSeptember 8, 2020, Beijing, Beijing, China: BeijingCHINA-On September 6, 2020, at the China International Trade in Services Fair 2020 in Beijing, domestic coVID-19 vaccines made their debut, attracting attention. Among them, the national medicine group China biological exhibited two new crown inactivated vaccine, now all are in the final period of ﾃ｢窶ｦﾂ｢ clinical trials. Will be on display at the firm sinovac coronavirus inactivated vaccines (Vero cell), at present also has entered the stage of ﾃ｢窶ｦﾂ｢ phase of clinical trial. (Credit Image: © SIPA Asia via ZUMA Wire)、クレジット：©ＳＩＰＡ Ａｓｉａ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｃｈｉｎａ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2020091008088
2020年09月09日Beijing: A china-made coVID-19 vaccine trade fair has made its debutSeptember 8, 2020, Beijing, Beijing, China: BeijingCHINA-On September 6, 2020, at the China International Trade in Services Fair 2020 in Beijing, domestic coVID-19 vaccines made their debut, attracting attention. Among them, the national medicine group China biological exhibited two new crown inactivated vaccine, now all are in the final period of ﾃ｢窶ｦﾂ｢ clinical trials. Will be on display at the firm sinovac coronavirus inactivated vaccines (Vero cell), at present also has entered the stage of ﾃ｢窶ｦﾂ｢ phase of clinical trial. (Credit Image: © SIPA Asia via ZUMA Wire)、クレジット：©ＳＩＰＡ Ａｓｉａ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ ※Ｃｈｉｎａ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2020091007764
2022年02月07日Israel - Researchers Engineer Human Spinal Cord ImplantsFebruary 7, 2022, Tel Aviv, Israel: Claiming a world first, Tel Aviv University researchers, led by Professor TAL DVIR, engineer human spinal cord implants for treating paralysis. Researchers from TAU Sagol Center for Regenerative Biotechnology engineered functional human spinal cord tissues from human materials and cells and implanted them in lab models. Following the implantation, 100% of the lab models with acute paralysis and 80% of those with chronic paralysis regained their ability to walk. Prof. Dvir: ‘‘We hope to reach the stage of clinical trials in humans within the next few years and ultimately get these patients back on their feet. (Credit Image: © Israel Hadari/Tau via ZUMA Press Wire)、クレジット：©Ｉｓｒａｅｌ Ｈａｄａｒｉ／Ｔａｕ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022020800332
2022年02月07日Israel - Researchers Engineer Human Spinal Cord ImplantsFebruary 7, 2022, Tel Aviv, Israel: Claiming a world first, Tel Aviv University researchers, led by Professor TAL DVIR, engineer human spinal cord implants for treating paralysis. Researchers from TAU Sagol Center for Regenerative Biotechnology engineered functional human spinal cord tissues from human materials and cells and implanted them in lab models. Following the implantation, 100% of the lab models with acute paralysis and 80% of those with chronic paralysis regained their ability to walk. Prof. Dvir: ‘‘We hope to reach the stage of clinical trials in humans within the next few years and ultimately get these patients back on their feet. (Credit Image: © Tel Aviv University via ZUMA Press Wire)、クレジット：©Ｔｅｌ Ａｖｉｖ Ｕｎｉｖｅｒｓｉｔｙ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022020800532
2022年02月07日Israel - Researchers Engineer Human Spinal Cord ImplantsFebruary 7, 2022, Tel Aviv, Israel: Claiming a world first, Tel Aviv University researchers, led by Professor TAL DVIR, engineer human spinal cord implants for treating paralysis. Researchers from TAU Sagol Center for Regenerative Biotechnology engineered functional human spinal cord tissues from human materials and cells and implanted them in lab models. Following the implantation, 100% of the lab models with acute paralysis and 80% of those with chronic paralysis regained their ability to walk. Prof. Dvir: ‘‘We hope to reach the stage of clinical trials in humans within the next few years and ultimately get these patients back on their feet. (Credit Image: © Israel Hadari/Tau via ZUMA Press Wire)、クレジット：©Ｉｓｒａｅｌ Ｈａｄａｒｉ／Ｔａｕ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2022020800308
- 1
